Idiopathic hypertrophic subaortic stenosis in the young

Area of Science:

• Cardiology
• Pediatric Cardiology
• Cardiovascular Surgery

Background:

• Idiopathic hypertrophic subaortic stenosis (IHSS) is a significant congenital heart defect.
• Diagnosis can be challenging, particularly in pediatric patients and those with atypical presentations.
• IHSS affects young patients, with symptoms including dyspnea, angina, and syncope.

Purpose of the Study:

• To evaluate the management strategies and outcomes for young patients diagnosed with IHSS.
• To compare the efficacy and safety of surgical intervention, propranolol treatment, and no therapy for IHSS.
• To identify diagnostic challenges associated with IHSS in pediatric populations.

Main Methods:

• Retrospective analysis of 36 young patients with IHSS, categorized by management approach.
• Group 1: Surgical intervention (n=16).
• Group 2: Propranolol treatment (n=7).
• Group 3: No therapy (n=13).
• Outcomes assessed included mortality (operative, late, sudden) and symptomatic improvement.

Main Results:

• Surgical intervention resulted in a 25% mortality rate (1 operative, 3 late deaths), with survivors experiencing symptom relief.
• Propranolol treatment demonstrated a 0% mortality rate.
• The untreated group had a 54% mortality rate (6 sudden deaths, 1 congestive cardiac failure).
• Diagnostic difficulties were noted in younger patients and those with asymptomatic murmurs.

Conclusions:

• IHSS is a serious condition requiring prompt diagnosis and management.
• Propranolol therapy is associated with favorable outcomes and no mortality in this cohort.
• Surgical intervention offers symptomatic improvement but does not eliminate the risk of sudden death.